As of January 22, 2025, IDEAYA Biosciences (IDYA) has a market cap of $2.00 billion USD. According to our data, IDEAYA Biosciences is ranked No.4139 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $2.00 B |
-10.08%
|
Dec 31, 2024 | $2.22 B |
-27.77%
|
Dec 29, 2023 | $3.08 B |
95.82%
|
Dec 30, 2022 | $1.57 B |
-23.14%
|
Dec 31, 2021 | $2.04 B |
68.86%
|
Dec 31, 2020 | $1.21 B |
86.67%
|
Dec 31, 2019 | $0.65 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Blueprint Medicines
BPMC
|
$7.10 B |
-0.000 M
|
USA
|
Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
USA
|
Revolution Medicines
RVMD
|
$7.60 B |
0.000 M
|
USA
|
Relay Therapeutics
RLAY
|
$0.81 B |
-0.000 M
|
USA
|
Zai Lab
ZLAB
|
$2.96 B |
0.128 B
|
China
|
Kura Oncology
KURA
|
$0.58 B |
-0.000 M
|
USA
|
Arcus Biosciences
RCUS
|
$1.24 B |
-0.000 M
|
USA
|
Iovance Biotherapeutics
IOVA
|
$1.78 B |
-0.017 B
|
USA
|
Fate Therapeutics
FATE
|
$0.15 B |
-0.000 M
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Adaptimmune Therapeutics
ADAP
|
$0.14 B |
0.000 M
|
UK
|
G1 Therapeutics
GTHX
|
$0.38 B |
0.000 M
|
USA
|
Market Cap | = | IDYA Stock Price | * | IDYA Shares Outstanding |
= | $23.11 | * | 86.43 M | |
= | $2.00 B |